Common TitlePROMISE
Official Title Simeprevir with Peginterferon and Ribavirin Leads to High Rates of SVR in Patients with HCV Genotype 1 who Relapsed after Previous Therapy: A Phase 3 Trial
Phase Phase III
ClinicalTrials.gov NCT01281839
Treatments
Simeprevir
Simeprevir
Tradename:OlysioOther Names:SMVClass:DiscontinuedFunding
IndustryJanssen